Example: Heart Attack

Clinical Trials on Microscopic Polyangiitis

Total 57 results

NCT03920722

Not yet recruiting

Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

Conditions: Microscopic Polyangiitis (MPA)
NCT03712345

Active, not recruiting

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

Conditions: Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA)
NCT03895801

Active, not recruiting

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

Conditions: Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA)
NCT01613599

Completed

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis
NCT00400075

Unknown status

CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors

Conditions: Polyarteritis Nodosa; Microscopic Polyangiitis
NCT00315393

Active, not recruiting

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Wegener's
NCT00405860

Completed

CellCept in p-ANCA Vasculitis

Conditions: MPO-ANCA Vasculitis; Microscopic Polyangiitis
NCT02115997

Recruiting

A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis

Conditions: Wegener's Granulomatosis or Microscopic Polyangiitis
NCT00104299

Completed

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Conditions: Vasculitis; Wegener's Granulomatosis; Microscopic Polyangiitis
NCT01750697

Completed

A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Conditions: Granulomatosis With Polyangiitis
NCT01598857

Withdrawn

BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis

Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis
NCT01408836

Terminated

Plasma Exchange for Renal Vasculitis

Conditions: Wegener's Granulomatosis; Microscopic Polyangiitis
NCT00748644

Completed

Efficacy Study of Two Treatments in the Remission of Vasculitis

Conditions: Wegener Granulomatosis; Microscopic Polyangiitis
NCT00647166

Completed

Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)

Conditions: MPA; PAN or EGPA With FFS=0; At Diagnosis or Within the First 15 Days Following Initiation of Corticosteroids
NCT02474888

Terminated

Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

Conditions: Granulomatosis, Wegener's; Microscopic Polyangiitis
NCT01586858

Terminated

Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis
NCT00987389

Completed

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis

Conditions: Granulomatosis With Polyangiitis (Wegener's) (GPA); Microscopic Polyangiitis (MPA)
NCT02169219

Completed

Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis

Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis
NCT01663623

Completed

Belimumab in Remission of VASculitis

Conditions: Vasculitis
NCT00753103

Completed

Anti-Cytokine Therapy for Vasculitis

Conditions: Wegener's Granulomatosis; Renal Limited Vasculitis; Microscopic Polyangiitis
NCT01729624

Unknown status

PRO Development for ANCA Associated Vasculitis

Conditions: Wegener Granulomatosis; Microscopic Polyangiitis; Churg-Strauss Syndrome
NCT00103792

Unknown status

Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)

Conditions: Wegener's Granulomatosis; Vasculitis
NCT01731561

Completed

Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis

Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Renal Limited Forms
NCT00307645

Terminated

IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis

Conditions: ANCA Associated Systemic Vasculitis Including Wegener's; Granulomatosis and Microscopic Polyangiitis and; Renal Limited Vasculitis
NCT02198248

Active, not recruiting

Low-dose Glucocorticoid Vasculitis Induction Study

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Microscopic Polyangiitis; Wegener Granulomatosis